reports
GPGI, Inc. Declares Dividend
GPGI, Inc. Declares Dividend NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- (NYSE: GPGI) (the “Company” or “GPGI”), a diversified multi-industry compounder comprising companies with great positions in good industries, today announced its Board of Directors has declared a quarterly cash dividend of $0.0025 per share of the Company’s Class A common stock. The dividend represents an annual distribution of approximately $2.9 million. GPGI’s capital allocation priorities remain focused on debt paydown and pursuing additional accretive acquisitions that meet the six pillars of our investment cri...
GPGI, Inc. Completes Rebrand and Starts Trading as GPGI on NYSE
GPGI, Inc. Completes Rebrand and Starts Trading as GPGI on NYSE Completed rebrand from CompoSecure, Inc. to GPGI, Inc. (“Great Positions in Good Industries”)Will begin trading under new name and ticker symbol “GPGI” on the New York Stock Exchange at market open on January 23rd CompoSecure and Husky will be two distinct reporting segments operating independently under GPGI NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- (NYSE: GPGI) (the “Company” or “GPGI”), a diversified multi-industry compounder comprised of companies with great positions in good industries, completed its previously ann...
CompoSecure, a Reporting Segment of GPGI, Inc, Announces CEO Transitio...
CompoSecure, a Reporting Segment of GPGI, Inc, Announces CEO Transition Appoints Graham Robinson as President and Chief Executive Officer of the CompoSecure reporting segmentAdds 30-year industry veteran with extensive global executive experience and deep expertise transforming industrial and technology companiesSupports the next phase of CompoSecure’s growth strategy SOMERSET, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (NYSE: CMPO), which will be renamed GPGI, Inc. (the “Company”), today announced its Board of Directors has appointed Graham Robinson as President and Chief...
CompoSecure Completes Debt Refinancing to Extend Maturities and Suppor...
CompoSecure Completes Debt Refinancing to Extend Maturities and Support Future Growth SOMERSET, N.J., Jan. 14, 2026 (GLOBE NEWSWIRE) -- (NYSE: CMPO) (the “Company” or “CompoSecure”) today announced that CompoSecure Holdings, L.L.C (the “issuer”), a direct, wholly owned subsidiary of the Company, has closed (i) its private placement of $900.0 million aggregate principal amount of senior secured notes due 2033 (the “Notes”), (ii) a new $1.2 billion term loan facility maturing in 2033 (the “New Term Loan”), and (iii) $400.0 million in revolving commitments maturing in 2031 (the “New Revolvi...
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2...
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced its preliminary, unaudited fourth quarter and full-year 2025 revenue results. Highlights: Preliminary revenue of $62.1 million to $62.5 million in the fourth quarter of 2025, an approximate 9% decrease at the midpoint over the same period ...
CompoSecure Completes Business Combination with Husky Technologies and...
CompoSecure Completes Business Combination with Husky Technologies and Rebrands Corporate Entity to GPGI, Inc. Completed business combination with Husky Technologies creating a $7.4 billion best-in-class, diversified compounderRebrands corporate entity to GPGI, Inc. (“Great Positions in Good Industries”) with two reporting segments CompoSecure and Husky Completed Business Combination SOMERSET, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) -- (NYSE: CMPO) completed its previously announced business combination with Husky Technologies Limited (“Husky”), a leader in highly engineered equipment and...
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ ...
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its Lapiplasty® Lightning™ technology. Lightning technology expands upon Treace’s market-leading Lapiplasty® System with advanced new instrumentation designed to reduce surgical steps, pr...
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference PONTE VEDRA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that John T. Treace, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, beginning at approximately 7:30 am PT. A live webcast and replay of the fireside chat will be available on the ...
CompoSecure, Inc. today announced that its stockholders have approved ...
CompoSecure, Inc. today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection with the proposed business combination with Husky Technologies Limited (“Husky”) SOMERSET, N.J., Dec. 24, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (NYSE: CMPO) today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection with the proposed business combination with Husky Technologies Limited (“Husky”). The business combination with Husky is expected to close in January 2026, subject t...
Treace Medical Secures Up to $175 Million in Debt Financing
Treace Medical Secures Up to $175 Million in Debt Financing New 5-Year Agreement Provides Continued Financial Strength & Flexibility PONTE VEDRA, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it has entered into a new five year $175 million senior secured loan arrangement with credit funds managed by SLR Capital Partners, consisting of $60 million in term loans funded at close,...
- Nicholas Cortellucci
- CFA
Ad-Tech Primer: Investing in the Future of Digital Advertising
What you need to know: • Public ad-tech equities are trading at historically low multiples, especially in Canada, despite consistent positive revenue growth and a pivot toward margin expansion. • Regulatory disruption and cookie deprecation are accelerating the shift to first-party data, contextual targeting, and AI-driven personalization. • Emerging channels like Connected TV and Retail Media are expanding monetization potential, creating asymmetric upside for nimble, vertically focused platfor...
Treace Announces Participation in Two Upcoming Investor Conferences
Treace Announces Participation in Two Upcoming Investor Conferences PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will participate in the following upcoming investor conferences. The UBS Global Healthcare Conference on Monday, November 10, 2025, with a fireside chat at 11:45 am ET; andThe Stifel 2025 Healthcare Conference on Tuesday, November 11, 2025 A live web...
Treace Medical Concepts Reports Third Quarter 2025 Financial Results
Treace Medical Concepts Reports Third Quarter 2025 Financial Results PONTE VEDRA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights Generated revenue of $50.2 million in third quarter 2025 representing growth of 11% over the same period in 2024. Reported third quarter 2025 net loss of $(16.3) million...
CompoSecure Reports Strong 3Q25 Financial Results and Announces Busine...
CompoSecure Reports Strong 3Q25 Financial Results and Announces Business Combination with Husky Technologies Strong operating performance delivered double-digit growth on both the top and bottom lineRaising full year 2025 guidance and issuing full year 2026 guidanceAnnounces business combination with Husky Technologies, creating a $7.4 billion best-in-class, diversified compounder SOMERSET, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (NYSE: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced its financial and operating results for the third quarte...
CompoSecure Schedules Third Quarter 2025 Conference Call for November ...
CompoSecure Schedules Third Quarter 2025 Conference Call for November 10th at 5:00 p.m. ET SOMERSET, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- . (NYSE: CMPO), a leader in metal payment cards, security, and authentication solutions, will host a conference call on Monday, November 10, 2025, at 5:00 p.m. Eastern Standard Time (EST) to discuss its financial results for the third quarter ended September 30, 2025. The Company’s results will be reported in a press release prior to the call. CompoSecure’s leadership will host the conference call, followed by a question-and-answer period. Date: Mo...
Treace to Report Third Quarter 2025 Financial Results on November 6, 2...
Treace to Report Third Quarter 2025 Financial Results on November 6, 2025 PONTE VEDRA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the third quarter 2025 after the close of trading on Thursday, November 6, 2025. Company management will host a conference call to discuss financial results beginning at 4:30 pm ET. Investors interested in...
CompoSecure Appoints Mary Holt as Chief Financial Officer
CompoSecure Appoints Mary Holt as Chief Financial Officer Brings a wealth of financial leadership from world-class organizations such as Honeywell and Pfizer SOMERSET, N.J., Oct. 09, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (NYSE: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced the appointment of Mary Holt as Chief Financial Officer (CFO), effective the day immediately following the filing of the Company's Q3 2025 Quarterly Report. She succeeds Tim Fitzsimmons who is retiring after a distinguished career with the company. As CFO, Ms. Hol...
- Dave Nicoski
- Ross LaDuke
ANTM ANTHEM INC.
SRPT SAREPTA THERAPEUTICS INC.
OMC OMNICOM GROUP INC
NEO NEOGENOMICS INC.
IPG INTERPUBLIC GROUP OF COMPANIES INC.
HELE HELEN OF TROY LIMITED
HAL HALLIBURTON COMPANY
AVA AVISTA CORPORATION
ANDE ANDERSONS INC.
ACGL ARCH CAPITAL GROUP LTD.
MDU MDU RESOURCES GROUP INC
POR PORTLAND GENERAL ELECTRIC COMPANY
THS TREEHOUSE FOODS INC.
TNDM TANDEM DIABETES CARE
AVTR AVANTOR INC.
VTRS VIATRIS INC.
REYN REYNOLDS CONSUMER PRODUCTS
VSTS_w VESTIS CORPORATION
Arculus and N.exchange Announce Partnership to Deliver Smarter, Better...
Arculus and N.exchange Announce Partnership to Deliver Smarter, Better-Priced Crypto Swaps Launches swap request Smart Order Router for the Arculus Cold Storage App SOMERSET, N.J., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Arculus, a CompoSecure technology (NYSE: CMPO), and N.exchange, a non-custodial cryptocurrency exchange/swap service, today announced a partnership to enhance in-app crypto swaps with broader access, improved pricing, and innovative routing technology. Through the agreement, N.exchange has been directly integrated into the Arculus Cold Storage Wallet, significantly expandi...
Treace Highlights New Product Innovations and Updated Positive Clinica...
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting PONTE VERDE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will highlight new product innovations and present new interim data for the ALIGN3D™ and MTA3D™ clinical studies at the American Orthopaedic Foot & Ankle Society (AOFA...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.